Daunorubicin- and Ara-C-induced interphasic apoptosis of human type II leukemia cells is caspase-8-independent
Related Experiment Video
Updated: Sep 21, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Anne-Dominique Terrisse1, Christine Bezombes, Sandra Lerouge
1Institut National de la Santé et de la Recherche Médicale E9910, Institut Claudius Régaud, 20 rue Pont St Pierre, 31052 Toulouse, France.
Abstract:
Drug-induced interphasic apoptosis in human leukemia cells is mediated through intracellular signaling pathways, of which the most proximal (initiating) event remains unclear. Indeed, both early ceramide generation and procaspase-8 cleavage have been individually identified as the initial apoptotic signaling events which precede the mitochondrial control of the apoptotic execution phase in Type II cells. In order to evaluate whether or not procaspase-8 cleavage is requisite for initial ceramide generation and rapid interphasic apoptosis, we investigated the chronological ordering of early ceramide generation and caspase-8 cleavage induced by daunorubicin (DNR) and 1-beta-D-arabinofuranosylcytosine (Ara-C) in U937 cells. We further evaluated the impact of these two drugs on initial ceramide generation and apoptosis in wild-type Jurkat cells and Jurkat clones mutated for caspase-8 and Fas-associated death domain. We show that while both DNR and Ara-C similarly induced early ceramide generation (within 5-20 min) and interphasic apoptosis in all cell models, caspase-8 cleavage was only observed farther downstream (4.5 h) and only in DNR-treated cells. Furthermore, neither DNR or Ara-C induced caspase-8 activation. These results demonstrate that caspase-8 cleavage is not requisite for the drug-induced activation of the ceramide-mediated interphasic apoptotic pathway in human Type II leukemic cells.
Insights
Drug-induced apoptosis in leukemia cells is initiated by ceramide generation, not caspase-8 cleavage. This finding clarifies the early signaling events in Type II leukemic cells, impacting cancer research.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Interphasic apoptosis in leukemia involves complex intracellular signaling pathways.
- The precise initiating event for drug-induced apoptosis in Type II cells remains unclear, with both ceramide generation and procaspase-8 cleavage proposed as early steps.
Purpose of the Study:
- To determine if procaspase-8 cleavage is essential for initial ceramide generation and rapid interphasic apoptosis.
- To investigate the chronological order of ceramide generation and caspase-8 cleavage induced by daunorubicin (DNR) and 1-beta-D-arabinofuranosylcytosine (Ara-C).
Main Methods:
- Investigated chronological ordering of ceramide generation and caspase-8 cleavage in U937 cells treated with DNR and Ara-C.
- Evaluated the impact of DNR and Ara-C on ceramide generation and apoptosis in wild-type Jurkat cells and Jurkat clones mutated for caspase-8 and Fas-associated death domain.
Main Results:
- Both DNR and Ara-C induced early ceramide generation (5-20 min) and interphasic apoptosis in all tested cell models.
- Caspase-8 cleavage was observed much later (4.5 h) and only in DNR-treated cells; neither drug induced caspase-8 activation.
- These findings indicate that caspase-8 cleavage is not required for the initial ceramide-mediated apoptotic pathway.
Conclusions:
- Procaspase-8 cleavage is not a requisite event for the initiation of drug-induced ceramide-mediated interphasic apoptosis in human Type II leukemic cells.
- Ceramide generation is the proximal initiating event in this apoptotic pathway, preceding caspase-8 involvement.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

